Cybin Inc.
A Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health conditions such as depression and anxiety. It engineers lab-modified versions of naturally occurring compounds, including psilocybin—the mushroom molecule behind the company's name. Founded in 2019, the firm later rebranded as Helus Pharma, pronounced "heal us."
No insider transactions reported in all recorded history.